OpenURL Connection Search

Select item for more details and to access through your institution.

Development of Customizable Implementation Guides to Support Clinical Adoption of Pharmacogenomics: Experiences of the Implementing GeNomics In pracTicE (IGNITE) Network.
Published in:
Pharmacogenomics & Personalized Medicine, 2020, v. 13, p. 217, doi. 10.2147/PGPM.S241599
By:
- Duong, Benjamin Q;
- Arwood, Meghan J;
- Hicks, J Kevin;
- Beitelshees, Amber L;
- Franchi, Francesco;
- Houder, John T;
- Limdi, Nita A;
- Cook, Kelsey J;
- Obeng, Aniwaa Owusu;
- Petry, Natasha;
- Tuteja, Sony;
- Elsey, Amanda R;
- Cavallari, Larisa H;
- Wiisanen, Kristin
Publication type:
Article
Investigating cognitive functioning in patients with chronic non-cancer pain (CNCP) before and during treatment with cannabis based medication -- a longitudinal pilot study (N=11).
Published in:
Scandinavian Journal of Pain, 2018, v. 18, p. S6, doi. 10.1515/sjpain-2018-9902
By:
- Würtzen, Hanne;
- Franchi, Francesco;
- Højsted, Jette
Publication type:
Article
Unmet needs in the management of acute myocardial infarction: role of novel protease-activated receptor-1 antagonist vorapaxar.
Published in:
2014
By:
- Cho, Jung Rae;
- Rollini, Fabiana;
- Franchi, Francesco;
- Ferrante, Elisabetta;
- Angiolillo, Dominick J
Publication type:
journal article
Unmet needs in the management of acute myocardial infarction: role of novel protease-activated receptor-1 antagonist vorapaxar.
Published in:
Vascular Health & Risk Management, 2014, v. 10, p. 177, doi. 10.2147/VHRM.S36045
By:
- Jung Rae Cho;
- Rollini, Fabiana;
- Franchi, Francesco;
- Ferrante, Elisabetta;
- Angiolillo, Dominick J.
Publication type:
Article
Therapeutic Potential of FXI Inhibitors: Hype or Hope?
Published in:
Drugs, 2024, v. 84, n. 9, p. 1055, doi. 10.1007/s40265-024-02049-w
By:
- Galli, Mattia;
- Occhipinti, Giovanni;
- Ortega-Paz, Luis;
- Franchi, Francesco;
- Rollini, Fabiana;
- Brugaletta, Salvatore;
- Capodanno, Davide;
- Sciarretta, Sebastiano;
- Angiolillo, Dominick J.
Publication type:
Article
Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials.
Published in:
European Heart Journal, 2022, v. 43, n. 10, p. 959, doi. 10.1093/eurheartj/ehab836
By:
- Galli, Mattia;
- Benenati, Stefano;
- Franchi, Francesco;
- Rollini, Fabiana;
- Capodanno, Davide;
- Biondi-Zoccai, Giuseppe;
- Vescovo, Giovanni Maria;
- Cavallari, Larisa H;
- Bikdeli, Behnood;
- Berg, Jurrien ten;
- Mehran, Roxana;
- Gibson, Charles Michael;
- Crea, Filippo;
- Pereira, Naveen L;
- Sibbing, Dirk;
- Angiolillo, Dominick J
Publication type:
Article
Role of oral anticoagulant therapy for secondary prevention in patients with stable atherothrombotic disease manifestations.
Published in:
Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719861475
By:
- Cho, Sung Won;
- Franchi, Francesco;
- Angiolillo, Dominick J.
Publication type:
Article
The role of oral anticoagulant therapy in patients with acute coronary syndrome.
Published in:
Therapeutic Advances in Hematology, 2017, v. 8, n. 12, p. 353, doi. 10.1177/2040620717733691
By:
- Moon, Jae Youn;
- Nagaraju, Deepa;
- Franchi, Francesco;
- Rollini, Fabiana;
- Angiolillo, Dominick J.
Publication type:
Article
Update on platelet glycoprotein IIb/IIIa inhibitors: recommendations for clinical practice.
Published in:
Therapeutic Advances in Cardiovascular Disease, 2013, v. 7, n. 4, p. 197, doi. 10.1177/1753944713487781
By:
- Muñiz-Lozano, Ana;
- Rollini, Fabiana;
- Franchi, Francesco;
- Angiolillo, Dominick J.
Publication type:
Article
Clinical implementation of rapid CYP2C19 genotyping to guide antiplatelet therapy after percutaneous coronary intervention.
Published in:
2018
By:
- Cavallari, Larisa H.;
- Franchi, Francesco;
- Rollini, Fabiana;
- Been, Latonya;
- Rivas, Andrea;
- Agarwal, Malhar;
- Smith, D. Max;
- Newsom, Kimberly;
- Gong, Yan;
- Elsey, Amanda R.;
- Starostik, Petr;
- Johnson, Julie A.;
- Angiolillo, Dominick J.
Publication type:
journal article
Evaluating the Effect of Estimating Renal Function With the CKD‐EPI 2021 Equation on the ABCD‐GENE Score for Clopidogrel Response Prediction.
Published in:
Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 5, p. 1227, doi. 10.1002/cpt.3385
By:
- AlSaeed, Maryam Jamal;
- Thomas, Cameron D.;
- Franchi, Francesco;
- Keeley, Ellen C.;
- Duarte, Julio D.;
- Gong, Yan;
- Rossi, Joseph S.;
- Beitelshees, Amber L.;
- Stouffer, George A.;
- Lee, Craig R.;
- Angiolillo, Dominick J.;
- Cavallari, Larisa H.
Publication type:
Article
Evaluation of Potential Racial Disparities in CYP2C19‐Guided P2Y12 Inhibitor Prescribing After Percutaneous Coronary Intervention.
Published in:
Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 3, p. 615, doi. 10.1002/cpt.2776
By:
- Cavallari, Larisa H.;
- Limdi, Nita A.;
- Beitelshees, Amber L.;
- Lee, James C.;
- Duarte, Julio D.;
- Franchi, Francesco;
- Tuteja, Sony;
- Giri, Jay;
- Empey, Philip E.;
- Kreutz, Rolf P.;
- Skaar, Todd C.;
- Allen, John M.;
- Coons, James C.;
- Gong, Yan;
- McDonough, Caitrin W.;
- Stevenson, James M.;
- Thomas, Cameron D.;
- Johnson, Julie A.;
- Stouffer, George A.;
- Angiolillo, Dominick J.
Publication type:
Article
Impact of the ABCD‐GENE Score on Clopidogrel Clinical Effectiveness after PCI: A Multi‐Site, Real‐World Investigation.
Published in:
Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 1, p. 146, doi. 10.1002/cpt.2612
By:
- Thomas, Cameron D.;
- Franchi, Francesco;
- Keeley, Ellen C.;
- Rossi, Joseph S.;
- Winget, Marshall;
- David Anderson, R.;
- Dempsey, Alyssa L.;
- Gong, Yan;
- Gower, Megan N.;
- Kerensky, Richard A.;
- Kulick, Natasha;
- Malave, Jean G.;
- McDonough, Caitrin W.;
- Mulrenin, Ian R.;
- Starostik, Petr;
- Beitelshees, Amber L.;
- Johnson, Julie A.;
- Stouffer, George A.;
- Winterstein, Almut G.;
- Angiolillo, Dominick J.
Publication type:
Article
Impact of the CYP2C19*17 Allele on Outcomes in Patients Receiving Genotype‐Guided Antiplatelet Therapy After Percutaneous Coronary Intervention.
Published in:
Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 3, p. 705, doi. 10.1002/cpt.2039
By:
- Lee, Craig R.;
- Thomas, Cameron D.;
- Beitelshees, Amber L.;
- Tuteja, Sony;
- Empey, Philip E.;
- Lee, James C.;
- Limdi, Nita A.;
- Duarte, Julio D.;
- Skaar, Todd C.;
- Chen, Yiqing;
- Cook, Kelsey J.;
- Coons, James C.;
- Dillon, Chrisly;
- Franchi, Francesco;
- Giri, Jay;
- Gong, Yan;
- Kreutz, Rolf P.;
- McDonough, Caitrin W.;
- Stevenson, James M.;
- Weck, Karen E.
Publication type:
Article
Multisite Investigation of Strategies for the Implementation of CYP2C19 Genotype‐Guided Antiplatelet Therapy.
Published in:
Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 4, p. 664, doi. 10.1002/cpt.1006
By:
- on behalf of the IGNITE Network;
- Empey, Philip E.;
- Stevenson, James M.;
- Coons, James C.;
- Owusu Obeng, Aniwaa;
- Peterson, Josh F.;
- Petry, Natasha;
- Pratt, Victoria M.;
- Scott, Stuart A.;
- Skaar, Todd C.;
- Stouffer, George A.;
- Wilke, Russell A.;
- Lee, Craig R.;
- Tuteja, Sony;
- Weitzel, Kristin W.;
- Johnson, Julie A.;
- Cavallari, Larisa H.;
- Angiolillo, Dominick J.;
- Franchi, Francesco;
- Rollini, Fabiana
Publication type:
Article
CYP2C19 Genotype Is Associated With Adverse Cardiovascular Outcomes in Black Patients Treated With Clopidogrel Undergoing Percutaneous Coronary Intervention.
Published in:
Journal of the American Heart Association, 2024, v. 13, n. 12, p. 1, doi. 10.1161/JAHA.123.033791
By:
- Tunehag, Kayla R.;
- Thomas, Cameron D.;
- Franchi, Francesco;
- Rossi, Joseph S.;
- Keeley, Ellen C.;
- Anderson, R. David;
- Beitelshees, Amber L.;
- Duarte, Julio D.;
- Yan Gong;
- Kerensky, Richard A.;
- McDonough, Caitrin W.;
- Nguyen, Anh B.;
- Paz, Luis Ortega;
- Venkatesh, Sanjay;
- Wang, Yehua;
- Johnson, Julie A.;
- Winterstein, Almut G.;
- Stouffer, George A.;
- Angiolillo, Dominick J.;
- Cavallari, Larisa H.
Publication type:
Article
Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention in Diverse Clinical Settings.
Published in:
2022
By:
- Beitelshees, Amber L.;
- Thomas, Cameron D.;
- Empey, Philip E.;
- Stouffer, George A.;
- Angiolillo, Dominick J.;
- Franchi, Francesco;
- Tuteja, Sony;
- A. Limdi, Nita;
- Lee, James C.;
- Duarte, Julio D.;
- Kreutz, Rolf P.;
- Skaar, Todd C.;
- Coons, James C.;
- Giri, Jay;
- McDonough, Caitrin W.;
- Rowland, Rachel;
- Stevenson, James M.;
- Thai, Thuy;
- Vesely, Mark R.;
- Wellen, Jacob T.
Publication type:
journal article
Pharmacodynamic Effects of Vorapaxar in Prior Myocardial Infarction Patients Treated With Potent Oral P2Y12 Receptor Inhibitors With and Without Aspirin: Results of the VORA-PRATIC Study.
Published in:
2020
By:
- Franchi, Francesco;
- Rollini, Fabiana;
- Faz, Gabriel;
- Rivas, Jose Ramon;
- Rivas, Andrea;
- Agarwal, Malhar;
- Briceno, Maryuri;
- Wali, Mustafa;
- Nawaz, Ahmed;
- Silva, Gabriel;
- Shaikh, Zubair;
- Maaliki, Naji;
- Fahmi, Kerolos;
- Been, Latonya;
- Pineda, Andres M.;
- Suryadevara, Siva;
- Soffer, Daniel;
- Zenni, Martin M.;
- Baber, Usman;
- Mehran, Roxana
Publication type:
journal article
Impact of Diabetes Mellitus and Chronic Kidney Disease on Cardiovascular Outcomes and Platelet P2Y12 Receptor Antagonist Effects in Patients With Acute Coronary Syndromes: Insights From the PLATO Trial.
Published in:
2019
By:
- Franchi, Francesco;
- James, Stefan K.;
- Lakic, Tatevik Ghukasyan;
- Budaj, Andrzej J.;
- Cornel, Jan H.;
- Katus, Hugo A.;
- Keltai, Matyas;
- Kontny, Frederic;
- Lewis, Basil S.;
- Storey, Robert F.;
- Himmelmann, Anders;
- Wallentin, Lars;
- Angiolillo, Dominick J.;
- Ghukasyan Lakic, Tatevik;
- PLATO Investigators
Publication type:
journal article
Impact of Diabetes Mellitus on the Pharmacodynamic Effects of Ticagrelor Versus Clopidogrel in Troponin-Negative Acute Coronary Syndrome Patients Undergoing Ad Hoc Percutaneous Coronary Intervention.
Published in:
2017
By:
- Sweeny, Joseph M.;
- Angiolillo, Dominick J.;
- Franchi, Francesco;
- Rollini, Fabiana;
- Waksman, Ron;
- Raveendran, Ganesh;
- Dangas, George;
- Khan, Naeem D.;
- Carlson, Glenn F.;
- Zhao, Yonggang;
- Teng, Renli;
- Mehran, Roxana
Publication type:
journal article
Role for Thrombin Receptor Antagonism With Vorapaxar in Secondary Prevention of Atherothrombotic Events: From Bench to Bedside.
Published in:
2018
By:
- Moon, Jae Youn;
- Franchi, Francesco;
- Rollini, Fabiana;
- Angiolillo, Dominick J.
Publication type:
journal article
Typical atrial flutter from blunt cardiac injury: an atypical cause.
Published in:
Journal of Geriatric Cardiology, 2021, v. 18, n. 2, p. 155, doi. 10.11909/j.issn.1671-5411.2021.02.009
By:
- Maaliki, Naji;
- Kandah, Fadi;
- Ali, Aleem Azal;
- Farah, James;
- Akinjogbin, Temitope;
- Franchi, Francesco
Publication type:
Article
Clinical and Pre-Clinical Pharmacokinetics and Pharmacodynamics of Bentracimab.
Published in:
Clinical Pharmacokinetics, 2023, v. 62, n. 5, p. 673, doi. 10.1007/s40262-023-01245-3
By:
- Ortega-Paz, Luis;
- Giordano, Salvatore;
- Franchi, Francesco;
- Rollini, Fabiana;
- Pollack Jr., Charles V.;
- Bhatt, Deepak L.;
- Angiolillo, Dominick J.
Publication type:
Article
Precision Antiplatelet Therapy after Percutaneous Coronary Intervention (Precision PCI) Registry – Informing optimal antiplatelet strategies.
Published in:
CTS: Clinical & Translational Science, 2024, v. 17, n. 8, p. 1, doi. 10.1111/cts.70004
By:
- Cavallari, Larisa H.;
- Lee, Craig R.;
- Franchi, Francesco;
- Keeley, Ellen C.;
- Rossi, Joseph S.;
- Thomas, Cameron D.;
- Gong, Yan;
- McDonough, Caitrin W.;
- Starostik, Petr;
- Al Saeed, Maryam J.;
- Been, Latonya;
- Kulick, Natasha;
- Malave, Jean;
- Mulrenin, Ian R.;
- Nguyen, Anh B.;
- Terrell, Joshua N.;
- Tillotson, Grace;
- Beitelshees, Amber L.;
- Winterstein, Almut G.;
- Stouffer, George A.
Publication type:
Article
Clinical Utility of Pharmacogene Panel‐Based Testing in Patients Undergoing Percutaneous Coronary Intervention.
Published in:
CTS: Clinical & Translational Science, 2020, v. 13, n. 3, p. 473, doi. 10.1111/cts.12729
By:
- El Rouby, Nihal;
- Alrwisan, Adel;
- Langaee, Taimour;
- Lipori, Gloria;
- Angiolillo, Dominick J;
- Franchi, Francesco;
- Riva, Alberto;
- Elsey, Amanda;
- Johnson, Julie A.;
- Cavallari, Larisa H.;
- Winterstein, Almut G.
Publication type:
Article
Impact of diabetes mellitus on the pharmacodynamic effects of prasugrel and ticagrelor after switching from clopidogrel in patients with coronary artery disease.
Published in:
Journal of Thrombosis & Thrombolysis, 2022, v. 54, n. 3, p. 461, doi. 10.1007/s11239-022-02696-4
By:
- Galli, Mattia;
- Rollini, Fabiana;
- Been, Latonya;
- Zenni, Martin M.;
- Angiolillo, Dominick J.;
- Franchi, Francesco
Publication type:
Article
Pharmacokinetic and pharmacodynamic profiles of a novel phospholipid-aspirin complex liquid formulation and low dose enteric-coated aspirin: results from a prospective, randomized, crossover study.
Published in:
Journal of Thrombosis & Thrombolysis, 2022, v. 54, n. 3, p. 373, doi. 10.1007/s11239-022-02687-5
By:
- Franchi, Francesco;
- Schneider, David J.;
- Prats, Jayne;
- Fan, Weihong;
- Rollini, Fabiana;
- Been, Latonya;
- Taatjes-Sommer, Heidi S.;
- Bhatt, Deepak L.;
- Deliargyris, Efthymios N.;
- Angiolillo, Dominick J.
Publication type:
Article
Use of the VerifyNow point of care assay to assess the pharmacodynamic effects of loading and maintenance dose regimens of prasugrel and ticagrelor.
Published in:
Journal of Thrombosis & Thrombolysis, 2021, v. 51, n. 3, p. 741, doi. 10.1007/s11239-021-02386-7
By:
- Angiolillo, Dominick J.;
- Been, Latonya;
- Rubinstein, Marc;
- Martin, Michael;
- Rollini, Fabiana;
- Franchi, Francesco
Publication type:
Article
Role of thromboelastography and rapid thromboelastography to assess the pharmacodynamic effects of vitamin K antagonists.
Published in:
Journal of Thrombosis & Thrombolysis, 2015, v. 40, n. 1, p. 118, doi. 10.1007/s11239-014-1130-1
By:
- Franchi, Francesco;
- Hammad, Jafri;
- Rollini, Fabiana;
- Tello-Montoliu, Antonio;
- Patel, Ronakkumar;
- Darlington, Andrew;
- Kraemer, Dale;
- Cho, Jung;
- DeGroat, Christopher;
- Bhatti, Mona;
- Taha, Mohamad;
- Angiolillo, Dominick
Publication type:
Article
Erratum to: Pharmacodynamic effects of EV-077 in patients with diabetes mellitus and coronary artery disease on aspirin or clopidogrel monotherapy: results of an in vitro pilot investigation.
Published in:
2014
By:
- Rollini, Fabiana;
- Tello-Montoliu, Antonio;
- Patel, Ronakkumar;
- Darlington, Andrew;
- Wilson, Ryan;
- Franchi, Francesco;
- Muñiz-Lozano, Ana;
- Desai, Bhaloo;
- Bender, Norbert;
- Sakariassen, Kjell;
- Angiolillo, Dominick
Publication type:
Erratum
Pharmacodynamic effects of EV-077 in patients with diabetes mellitus and coronary artery disease on aspirin or clopidogrel monotherapy: results of an in vitro pilot investigation.
Published in:
Journal of Thrombosis & Thrombolysis, 2014, v. 37, n. 2, p. 131, doi. 10.1007/s11239-013-0979-8
By:
- Rollini, Fabiana;
- Tello-Montoliu, Antonio;
- Patel, Ronakkumar;
- Darlington, Andrew;
- Wilson, Ryan;
- Franchi, Francesco;
- Muñiz-Lozano, Ana;
- Desai, Bhaloo;
- Bender, Norbert;
- Sakariassen, Kjell;
- Angiolillo, Dominick
Publication type:
Article
Effect of lipid-lowering therapy on platelet reactivity in patients treated with and without antiplatelet therapy.
Published in:
Minerva Cardiology & Angiology, 2024, v. 72, n. 5, p. 489, doi. 10.23736/S2724-5683.23.06411-6
By:
- GIORDANO, Salvatore;
- FRANCHI, Francesco;
- ROLLINI, Fabiana;
- AL SALEH, Tala;
- UZUNOGLU, Ekin;
- COSTA, Francesco;
- ANGIOLILLO, Dominick J.;
- ORTEGA-PAZ, Luis
Publication type:
Article
Dual pathway inhibition in atherothrombosis prevention: yes, now we can!
Published in:
Minerva Cardiology & Angiology, 2023, v. 71, n. 4, p. 363, doi. 10.23736/S2724-5683.21.05867-1
By:
- SUMMARIA, Francesco;
- BIONDI-ZOCCAI, Giuseppe;
- ROMAGNOLI, Enrico;
- MAMAS, Mamas A.;
- FRANCHI, Francesco;
- SEVERINO, Paolo;
- LAVALLE, Carlo;
- VERSACI, Francesco;
- GASPARDONE, Achille;
- BHATT, Deepak L.
Publication type:
Article
A head-to-head pharmacodynamic comparison of prasugrel vs. ticagrelor after switching from clopidogrel in patients with coronary artery disease: results of a prospective randomized study.
Published in:
European Heart Journal, 2016, v. 37, n. 35, p. 2722, doi. 10.1093/eurheartj/ehv744
By:
- Rollini, Fabiana;
- Franchi, Francesco;
- Jung Rae Cho;
- DeGroat, Christopher;
- Bhatti, Mona;
- Muniz-Lozano, Ana;
- Singh, Kamaldeep;
- Ferrante, Elisabetta;
- Wilson, Ryan E.;
- Dunn, Elizabeth C.;
- Zenni, Martin M.;
- Guzman, Luis A.;
- Bass, Theodore A.;
- Angiolillo, Dominick J.
Publication type:
Article

Found: 34

Development of Customizable Implementation Guides to Support Clinical Adoption of Pharmacogenomics: Experiences of the Implementing GeNomics In pracTicE (IGNITE) Network.

Investigating cognitive functioning in patients with chronic non-cancer pain (CNCP) before and during treatment with cannabis based medication -- a longitudinal pilot study (N=11).

Unmet needs in the management of acute myocardial infarction: role of novel protease-activated receptor-1 antagonist vorapaxar.

Unmet needs in the management of acute myocardial infarction: role of novel protease-activated receptor-1 antagonist vorapaxar.

Therapeutic Potential of FXI Inhibitors: Hype or Hope?

Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials.

Role of oral anticoagulant therapy for secondary prevention in patients with stable atherothrombotic disease manifestations.

The role of oral anticoagulant therapy in patients with acute coronary syndrome.

Update on platelet glycoprotein IIb/IIIa inhibitors: recommendations for clinical practice.

Clinical implementation of rapid CYP2C19 genotyping to guide antiplatelet therapy after percutaneous coronary intervention.

Evaluating the Effect of Estimating Renal Function With the CKD‐EPI 2021 Equation on the ABCD‐GENE Score for Clopidogrel Response Prediction.

Evaluation of Potential Racial Disparities in CYP2C19‐Guided P2Y<sub>12</sub> Inhibitor Prescribing After Percutaneous Coronary Intervention.

Impact of the ABCD‐GENE Score on Clopidogrel Clinical Effectiveness after PCI: A Multi‐Site, Real‐World Investigation.

Impact of the CYP2C19*17 Allele on Outcomes in Patients Receiving Genotype‐Guided Antiplatelet Therapy After Percutaneous Coronary Intervention.

Multisite Investigation of Strategies for the Implementation of CYP2C19 Genotype‐Guided Antiplatelet Therapy.

CYP2C19 Genotype Is Associated With Adverse Cardiovascular Outcomes in Black Patients Treated With Clopidogrel Undergoing Percutaneous Coronary Intervention.

Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention in Diverse Clinical Settings.

Pharmacodynamic Effects of Vorapaxar in Prior Myocardial Infarction Patients Treated With Potent Oral P2Y<sub>12</sub> Receptor Inhibitors With and Without Aspirin: Results of the VORA-PRATIC Study.

Impact of Diabetes Mellitus and Chronic Kidney Disease on Cardiovascular Outcomes and Platelet P2Y<sub>12</sub> Receptor Antagonist Effects in Patients With Acute Coronary Syndromes: Insights From the PLATO Trial.

Impact of Diabetes Mellitus on the Pharmacodynamic Effects of Ticagrelor Versus Clopidogrel in Troponin-Negative Acute Coronary Syndrome Patients Undergoing Ad Hoc Percutaneous Coronary Intervention.

Role for Thrombin Receptor Antagonism With Vorapaxar in Secondary Prevention of Atherothrombotic Events: From Bench to Bedside.

Typical atrial flutter from blunt cardiac injury: an atypical cause.

Clinical and Pre-Clinical Pharmacokinetics and Pharmacodynamics of Bentracimab.

Precision Antiplatelet Therapy after Percutaneous Coronary Intervention (Precision PCI) Registry – Informing optimal antiplatelet strategies.

Clinical Utility of Pharmacogene Panel‐Based Testing in Patients Undergoing Percutaneous Coronary Intervention.

Impact of diabetes mellitus on the pharmacodynamic effects of prasugrel and ticagrelor after switching from clopidogrel in patients with coronary artery disease.

Pharmacokinetic and pharmacodynamic profiles of a novel phospholipid-aspirin complex liquid formulation and low dose enteric-coated aspirin: results from a prospective, randomized, crossover study.

Use of the VerifyNow point of care assay to assess the pharmacodynamic effects of loading and maintenance dose regimens of prasugrel and ticagrelor.

Role of thromboelastography and rapid thromboelastography to assess the pharmacodynamic effects of vitamin K antagonists.

Erratum to: Pharmacodynamic effects of EV-077 in patients with diabetes mellitus and coronary artery disease on aspirin or clopidogrel monotherapy: results of an in vitro pilot investigation.

Pharmacodynamic effects of EV-077 in patients with diabetes mellitus and coronary artery disease on aspirin or clopidogrel monotherapy: results of an in vitro pilot investigation.

Effect of lipid-lowering therapy on platelet reactivity in patients treated with and without antiplatelet therapy.

Dual pathway inhibition in atherothrombosis prevention: yes, now we can!

A head-to-head pharmacodynamic comparison of prasugrel vs. ticagrelor after switching from clopidogrel in patients with coronary artery disease: results of a prospective randomized study.